Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinicopathologic analysis of k-ras, p53, and ERBB-2 gene alterations in pulmonary adenocarcinoma.

Diagnostic molecular pathology : the American journal of surgical pathology, part B - 1 Feb 1997

Visscher D W, Yadrandji S, Tabaczka P, Kraut M, Sarkar F H

Abstract excerpt

We compared PCR-SSCP detected mutations of k-ras (codon 12) and p53 (exons 5-8) to ERBB-2 immunostaining and clinicopathologic features in 31 pulmonary adenocarcinomas. There were nine tumors (29%) with mutations of ras, 13 tumors (42%) with mutations of p53, and three tumors (10%) with mutations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, erbB-2

Share to Genes, p53

Share to Genes, ras

Share to Lung Neoplasms

Share to Mutation

Source

Identifiers

PMID: 9028739
DOI: 10.1097/00019606-199702000-00010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-9028739-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinicopathologic analysis of k-ras, p53, and ERBB-2 gene alterations in pulmonary adenocarcinoma.PMID 9028739Read ↗

C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas.Semantic proximity Read ↗

Detection of K-ras mutations in lung carcinomas: relationship to prognosis.Semantic proximity Read ↗

Implications and prognostic value of K-ras mutation for early-stage lung cancer in women.Semantic proximity Read ↗

Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas.Semantic proximity Read ↗

BRONCHIOLOALVEOLAR LUNG CARCINOMAS: K-ras MUTATIONS ARE CONSTANT EVENTS IN THE MUCINOUS SUBTYPESemantic proximity Read ↗

Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.Semantic proximity Read ↗

K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung.Semantic proximity Read ↗

Overexpression of Bcl-2 and mutations in p53 and K-ras in resected human non-small cell lung cancers.Semantic proximity Read ↗

Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma.Semantic proximity Read ↗

FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.Semantic proximity Read ↗

Detection of K-ras mutations of bronchoalveolar lavage fluid cells aids the diagnosis of lung cancer in small pulmonary lesions.Semantic proximity Read ↗

K-ras genotypes and prognosis in non-small-cell lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.